We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$296M
AUM Growth
-$4.31M
Cap. Flow
+$86.6K
Cap. Flow %
0.03%
Top 10 Hldgs %
47.38%
Holding
588
New
23
Increased
63
Reduced
57
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 52.09%
2 Healthcare 7.88%
3 Consumer Staples 6.24%
4 Industrials 5.95%
5 Financials 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEC icon
551
Fidelity MSCI Information Technology Index ETF
FTEC
$20.3B
-1
Closed -$225
LUMN icon
552
Lumen
LUMN
$6.9B
-7
Closed -$54
LUV icon
553
Southwest Airlines
LUV
$23.3B
-2
Closed -$83
NOTE
554
DELISTED
FiscalNote
NOTE
-12
Closed -$18
OGN icon
555
Organon & Co
OGN
$3.55B
-3
Closed -$18
OXY.WS icon
556
Occidental Petroleum Corp Warrants
OXY.WS
$33.4B
-12
Closed -$231
RLMD icon
557
Relmada Therapeutics
RLMD
$525M
-2
Closed -$10
SONY icon
558
Sony
SONY
$123B
-300
Closed -$7.68K
TLRY icon
559
Tilray
TLRY
$514M
-8
Closed -$72
VTRS icon
560
Viatris
VTRS
$19.8B
-4
Closed -$53
VYX icon
561
NCR Voyix
VYX
$1.07B
-12
Closed -$122
XRX icon
562
Xerox
XRX
$348M
-25
Closed -$60
AIFD
563
TCW Artificial Intelligence ETF
AIFD
$133M
-109
Closed -$4.1K
TSYY
564
GraniteShares YieldBOOST TSLA ETF
TSYY
$68.4M
0
-$11
XYZ
565
Block Inc
XYZ
$46.1B
-1
Closed -$65
TVRD
566
Tvardi Therapeutics
TVRD
$25.9M
-1
Closed -$4
LL
567
DELISTED
LL Flooring Holdings, Inc.
LL
-25
Closed
FSR
568
DELISTED
Fisker Inc.
FSR
-1,000
Closed
FRC
569
DELISTED
First Republic Bank
FRC
-325
Closed
NAVB
570
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-280
Closed
FCRE
571
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
-1
Closed
MBLY
572
DELISTED
Mobileye N.V.
MBLY
-34
Closed
COYY
573
GraniteShares YieldBOOST COIN ETF
COYY
$20M
0
-$8

Similar funds

Front Row Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Front Row Advisors held 588 positions worth $296M, down 1.4% from $300M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Front Row Advisors's Q1 2026 filing shows 23 new, 63 increased, 57 reduced and 32 closed positions. Its largest new stake was Blackstone: 500 shares worth $57.5K. The largest sale was NVIDIA, an estimated $466K.

By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 53% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q1 2026 buy was Blackstone: 500 shares worth $57.5K.
  • Front Row Advisors added most to Arbutus Biopharma in Q1 2026, an estimated $437K increase.
  • Front Row Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $466K.
  • Front Row Advisors fully exited Confluent in Q1 2026, selling an estimated $24.2K.
  • Front Row Advisors's ten largest holdings make up 47% of its $296M portfolio in Q1 2026.
  • Front Row Advisors opened 23 new positions and closed 32 in Q1 2026.
  • Front Row Advisors's portfolio value fell 1.4% quarter-over-quarter to $296M.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.